A trial of clarithromycin for the treatment of suboptimally controlled asthma

PCR studies have demonstrated evidence of Mycoplasma pneumoniae and Chlamydophila pneumoniae in the lower airways of patients with asthma.To test the hypothesis that clarithromycin would improve asthma control in individuals with mild-to-moderate persistent asthma that was not well controlled despite treatment with low-dose inhaled corticosteroids.Adults with an Asthma Control Questionnaire score ≥1.5 after a 4-week period of treatment with...